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Abstract 
BACKGROUND:   Inappropriate antibiotic prescribing is a well-documented global health crisis 
(Centers for Disease Control, CDC, 2013).  Antimicrobial stewardship (AS) is the purposeful 
selection of the correct drug, dose, route and duration of antimicrobial treatment to decrease 
microbial resistance, adverse drug effects and cost while improving patient outcomes (Dellit et 
al., 2007; CDC, 2016).  Antimicrobial Stewardship Programs (ASP) are multidisciplinary 
programs designed to improve AS.   
PURPOSE: To describe baseline prescribing patterns and evaluate the effect of an antimicrobial 
stewardship program (ASP) for adult acute sinusitis on provider knowledge and antibiotic 
prescribing practice. among primary care providers in an internal medicine clinic in an academic 
medical center in Kentucky  
METHODS: In this pre/post-test quasi-experimental design study a baseline chart audit was 
conducted to determine baseline prescribing practices.  An evidence based ASP was developed 
and implemented to assess pre/post provider knowledge as determined by changes survey scores 
after the education based ASP.  Following the ASP, a focus group structured on the Health Belief 
Model was conducted to elicit perceived barriers to deliver guideline recommended care.   
RESULTS:  The sample contained 22 patient chats for the baseline chart audit. The chart audits 
revealed that care was concordant the majority (59.1%) of the time, the lowest scoring 
component of the chart audit was timing (50%) and was significantly different between 
concordant and unconcordant care.  Eleven providers completed the pretest and participated in 
the ASP and focus group 9 of the 11 providers completed the post-test 1 week after the ASP.  
Overall knowledge increased from after the ASP 
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 (M = 52.27, SD =26.11) vs. (M = 55.56, SD = 24.3). Concordant care was delivered in 59.1% of 
cases.  Providers reported a desire for support in appropriate prescribing and in educating 
patients on appropriate antibiotic use.   
CONCLUSION:  Care was concordant the majority (59.1%) of the time, and correct antibiotic 
selection occurred 100%.  Key areas for improvement include waiting for long enough symptom 
duration … correct symptom duration.  The ASP was feasible to implement and was well 
received by attendees. Future ASP sessions should include a multidisciplinary team, multiple 
sessions which include active participation, and communication skills.  Future studies should 
identify specific provider, clinical and patient components that influence the effectiveness of 
outpatient stewardship programs.   
Keywords:  Antimicrobial Stewardship Program, Sinusitis, Adult, Antibiotics 
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Adult Acute Sinusitis Antimicrobial Stewardship Program in a Primary Care Setting 
Inappropriate antibiotic prescribing is a well-documented global health crisis (Centers for 
Disease Control, CDC, 2013).  The National Action Plan for Combating Antibiotic-Resistant 
Bacteria calls for reducing inappropriate outpatient antibiotics by 50% by the year 2020 (The 
White House, 2015).  As many as 50% of outpatient antibiotics prescribed are unnecessary 
and/or inappropriate (CDC, 2016) and acute respiratory conditions result in the most frequent 
inappropriate antibiotic prescribing (Fleming et al, 2016).  Thirty million adults report being 
diagnosed with a sinus infection annually and although  84% of sinusitis cases are viral, 82.7% 
of visits resulted in an antibiotic prescription (Blackwell, Lucas & Clarke, 2014; Sharp, Deman, 
Puumala, Leopold, 2007).  Due to gross misuse of antimicrobial agents, the Infectious Disease 
Society of America (IDSA) along with the CDC advocate for the creation and implementation of 
antimicrobial stewardship programs (ASPs) to promote prescription of the right drug, dose and 
duration of antibiotics (CDC, 2013; Dellit et al., 2007; IDSA, 2011).  The purpose of this study is 
to improve antibiotic prescribing and stewardship related to adults with acute sinusitis in the 
outpatient setting  
Background 
Antibiotic Use 
An estimated 262.5 million antibiotics are prescribed each year (CDC, 2015).  
Nationwide, five prescriptions are written for every six people (CDC, 2015).  Kentucky has the 
highest antibiotic prescribing rate in the country, with 1281 antibiotics prescribed per 1000 
people (Hicks, 2014).  Up to 50% of antibiotics prescribed are inappropriate, 33% are 
unnecessary, and 64% of all antibiotics prescribed are written in the outpatient setting (Fleming 
et al, 2016; Hicks, 2014).  Respiratory tract infections receive the highest number of antibiotics 
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in the outpatient setting (CDC, 2016).  Inappropriate antibiotics are those which are an incorrect 
drug, dose, route or indication.  Unnecessary antibiotics are those prescribed without an 
indication, such as too early in the natural course of a disease.   
Resistance and Stewardship 
Inappropriate antimicrobial use is described as prescription of non-optimal antibiotic 
regimen, dose, duration and route (IDSA, 2011); it can cause iatrogenic harm such as clostridium 
difficile (Dantes et al, 2015).  Inappropriate antimicrobial use also contributes to the evolution of 
bacterial resistance (Goossens, Ferech, Vander Stichele, & Elseviers, 2005).  Antibiotic resistant 
infections account for 20 billion dollars in health care costs and a loss of 35 billion dollars in 
productivity each year (CDC, 2013). Superbug infections occur at a crude rate of 2 million 
people infected annually in the United States, with 23,000 deaths directly due to resistant 
infections (CDC, 2013).  Due to these sequelae, the IDSA and the CDC advocate for the creation 
and implementation of antimicrobial stewardship programs (ASPs) to promote prescription of 
the right drug, dose, duration and route of antibiotics (CDC, 2013; Dellit et al., 2007; IDSA, 
2011). ASPs are also aligned with The National Action Plan for Combating Antibiotic-Resistant 
Bacteria, which has the goal for reducing unnecessary antibiotic use by 50% by the year 2020 
(The White House, 2015). 
Though ASP success within the inpatient setting has been validated by many studies, 
fewer studies have been conducted in the outpatient and primary care settings (Arnold & Straus, 
2005; Ranji, Steinman, Shojania & Gonzales, 2008; Song 2014).  Research on inpatient 
stewardship has taken precedence due to the 2013 CDC Antibiotic/Antimicrobial Resistance 
Threat Report, which ranks Clostridium Difficile as an urgent resistance threat.  Stewardship in 
the outpatient setting is a currently evolving area of practice.   
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To support outpatient stewardship, The CDC’s Get Smart: Know When Antibiotics Work 
campaign (2016) identified four core elements of outpatient antimicrobial stewardship program 
development: (a) Commitment to stewardship on a multidisciplinary level; (b) Action for policy 
and practice to support stewardship; (c) Tracking and reporting of antibiotic use and drug 
resistance; (d) education and expertise on current guidelines, practice behavior, and drug 
resistance.  These core elements are consistent with previous guideline and Cochrane Review 
recommendations. The Core elements simplify the 2007 IDSA recommendations for ASP 
creation and implementation and the 2005 Cochrane review of interventions for ambulatory 
stewardship through organizing intervention by category, or element.  The Get Smart campaign 
also contains information for patients, providers, measurements, partnerships and references; 
meaningful uses of this information ranges from vague to explicit (CDC, 2015).   
Acute Sinusitis Antimicrobial Stewardship.  Acute respiratory tract infections account 
for the majority of inappropriate antibiotic prescriptions in the outpatient setting (Fleming et al, 
2016; Blackwell, Lucas & Clarke, 2014).  One in eight adults (30 million or 11.8% of adults) 
report being diagnosed with a sinus infection every year (Blackwell, Lucas & Clark, 2014).  
Consistent with other URIs, 84% of sinusitis cases are viral (Autio et al., 2015; Gwaltney, 
Wiesinger, & Patrie, 2004), however 82.75% of outpatient sinusitis visits resulted in an antibiotic 
prescription (Fairlie, Shapiro, Hersh & Hicks, 2012; Sharp, Deman, Puumala & Leopold, 2007).  
Inappropriate antibiotic use for URI treatment, including sinusitis, is linked to antibiotic 
resistance (Costelloe, Metcalfe, Lovering, Mandt, & Hay, 2010; Goossens, Ferech, Vander 
Stichele, & Elseviers, 2005).   Practicing stewardship for acute sinusitis is an important primary 
care stewardship focus, since acute sinusitis accounts for the majority of outpatient antibiotic 
prescriptions (15-21% of adult outpatient antibiotics) (Fairlie, Shapiro, Hersh & Hicks, 2012).      
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The American Academy of Otolaryngology – Head and Neck Surgery (AAO-HNS) 
published a 2015 clinical practice guideline update to improve appropriate antibiotic use for 
acute sinusitis (Rosenfeld et al., 2015) The guideline update expanded the recommendation from 
treating acute sinusitis with Amoxicillin to Amoxicillin with or without Clavulanate or watchful 
waiting.  Treatment should be initiated after 10 days of symptoms or the presence of double 
sickening.  Diagnostic symptoms of acute sinusitis are: purulent nasal drainage, with or without 
nasal obstruction/congestion, and/or facial pain and pressure.  The practice change supports 
provider autonomy and accounts for regional resistance rates.  Regional resistance rates to 
Amoxicillin range to 35% for strep pneumonia, haemophilus influenza, and moraxella 
catarrhalis, with susceptibility to Amoxicillin-Clavulanate of over 99% (IDSA, 2012).  The CDC 
endorses the Rosenfeld et al.’s 2015 AAO-HNS Clinical Practice Guideline Update as 
recommended treatment for acute sinusitis (CDC, 2016).   
In addition to finding 82.75% of acute sinusitis cases received an antibiotic, Fairlie et al. 
(2012) analyzed population based surveys, National Ambulatory Medical Care Survey 
(NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS) data, and 
reported the nationwide proportion of antibiotics prescribed for adult acute sinusitis as follows: 
amoxicillin with or without clavulanate (33%; 17% and 16% respectively), macrolide (29%), 
quinolone (19%) and cephalosporin/other (19%).  During the time period of Fairlie et al., 2012 
study, the guideline recommended therapy was amoxicillin only, leading researchers to separate 
amoxicillin (17%) from amoxicillin with clavulanate (16%) and state the most common 
antibiotics prescribed for adult acute sinusitis were macrolides (29%) (Fairlie et al, 2012; Chow 
et al, 2012). Combining amoxicillin with or without clavulanate to meet current guidelines 
(Rosenfeld et al, 2015) indicates the most common antibiotics prescribed for adult acute sinusitis 
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were amoxicillin with or without clavulanate (33%).  For this project, amoxicillin with or 
without clavulanate were combined to represent 33% of antibiotics prescribed for adult acute 
sinusitis.   
In addition to clinical practice guidelines, there are also quality measures through the 
Centers for Medicare and Medicaid to provide financial incentive for guideline-adherent care.  
The 2016 Physicians Quality Reporting System (PQRS, 2016) measure #331 recommends 
treatment of adults with acute sinusitis with Amoxicillin with or without Clavulanate or watchful 
waiting.  PQRS #332 recommends ideal antibiotic treatment should occur after ten days and 
before four weeks of symptoms or with the presence of double sickening (worsening of 
symptoms after initial improvement).  PQRS is a merit-based incentive payment system through 
the Centers for Medicare and Medicaid (CMS) (CMS, 2015).  Treatment information for 
measures #331 and #332 is based on Rosenfeld et al.’s (2015) AAO-HNS evidence 2015 Clinical 
Practice Update: Adult Sinusitis.  Because of the potential influence on reimbursement and 
recommendations consistent with the CDC’s practice guidelines, the PQRS measures #331 and 
#332 served as the quality measures to help develop the education based ASP and evaluate 
weather practice was consistent with guideline recommended care.    
Purpose 
The purpose of this study was to describe baseline prescribing patterns and evaluate the 
effect of an antimicrobial stewardship program (ASP) for adult acute sinusitis on provider 
knowledge and perceived practice.  The objective was to evaluate the effect of the education 
based ASP by comparing pre/post provider knowledge and practice.  This purpose is consistent 
with The National Action Plan for Combating Antibiotic-Resistant Bacterial (The White House, 
2015), the IDSA (2011), and the CDC (2017).  
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Specific aims:  
• Assess baseline antibiotic prescribing patterns for acute sinusitis in adult patients. 
• Develop and implement an evidence based ASP based on PQRS measures #331 
and #332 for primary care providers  
• Evaluate effects of ASP implementation on provider knowledge related to 
antibiotic prescribing standards for acute sinusitis in adults. 
Methods 
Design 
 This study was a pre-test/posttest quasi-experimental design with a descriptive 
retrospective chart audit and focus group.  The study contained three phases:  
1. Phase 1: Baseline Assessment 
• Provider Knowledge: Survey on PQRS measures #331 and #332 
• Prescribing Patterns: Retrospective chart audit on diagnosis and treatment 
of sinusitis per PQRS measures #331 and #332 
2. Phase 2: Educational Intervention  
• ASP: created by the PI, based on the CDC recommendations and PQRS 
measures #331 and #332 
• Focus group following ASP 
3. Phase 3: Post Assessment  
• Provider Knowledge: Survey 
• Prescribing Patterns: Chart Audit  
All aspects of this study were approved by the Institutional Review Board (IRB), Nursing 
Research Council & Internal Medicine Research Council prior to implementation. This ASP was 
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evidence based, but only able to use two of the CDC’s four elements to outpatient antimicrobial 
stewardship: tracking and reporting, and education and expertise (CDC, 2016). 
Setting and Sample 
This was a single center study, conducted at an internal medicine clinic in an academic 
medical center in Kentucky. Two sample groups consisted of 1) providers and 2) patients 
(indirectly through their medical records).   
Providers.  The provider population included voluntary non-resident primary care 
providers (physicians, advance practice registered nurses, and physician’s assistants) at the 
internal medicine clinic.  Provider demographics were not collected to maintain anonymity with 
a small sample size.  Providers who participated in the focus group completed informed consent 
forms. Those providers who completed the knowledge surveys were given survey cover letters 
with a waiver of informed consent (Appendices A, B, C and D).  All consent forms contained the 
following information: purpose, risks, benefits, procedures, voluntary participation, anonymity, 
counseling, and PI contact information. 
Patients.  Assessment of the patient population included a retrospective chart audit of 22 
randomly sampled adult patients (>18 years) with ICD 9 or 10 codes (Table 3) for acute sinusitis 
who were treated between March 15-June 15, 2016 at the internal medicine clinic.   A random 
selection of charts was performed by the UK Center for Clinical and Translational Science 
(CCTS) Enterprise Data Trust (EDT). CCTS is a recognized as a third party honest broker and 
data proprietor.  Demographic information included: gender, age, race, and insurance type.  A 
waiver of informed consent was submitted for the retrospective chart audit since information 
used was previously collected for non-research purposes. 
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  CCTS provided a list of 499 encounters with medical record numbers mined using a 
query with the inclusion criteria of: adult patients (>18 years) treated between March 15-June 15, 
2016 at the internal medicine clinic with ICD 10 codes for sinusitis (J01.00, J01.10, 
J01.20, J01.30, J01.40, J01.80, J01.90).   The majority of patient encounters were excluded for 
the following reasons: (a) pediatric patient; (b) other outpatient clinic within the academic 
medical center’s healthcare system; (c) duplicated medical record number; and (d) no diagnosis 
of acute sinusitis.   
Procedures  
 Phase 1. 
Baseline retrospective chart audit. The baseline assessment chart audit was conducted on 
a sample of 22 randomly selected adult (>18 years) patients seeking treatment at the internal 
medicine clinic with acceptable acute sinusitis ICD codes (J01.00, J01.10, J01.20, J01.30, 
J01.40, J01.80, J01.90) between March 15-June 15, 2016.  Power analysis determined a 
necessary sample size of 103 randomly selected adult patients to achieve a power of 80% with an 
alpha of .05; however, data received from CCTS had insufficient patient numbers meeting the 
inclusion criteria and only a total of 22 patients were eligible for review.  
Patient variables assessed included: patient age, gender, race, and insurance type.    
Clinical variables assessed were pertinent to the diagnosis and treatment of adult acute sinusitis, 
and included: diagnosis of sinusitis, allergies, symptoms (including presence of double 
sickening), timing of diagnosis, and treatment (including antibiotic prescription, indications for 
an alternative to first-line antibiotic treatment, and dose of antibiotic). Key measures on the chart 
audit tool examined if care was concordant or unconcordant to PQRS measures #331 and #332, 
Concordant care was defined as correct documentation of: symptoms (purulent nasal drainage 
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with or without facial pain and nasal obstruction), for the correct duration of time (10 days to 4 
weeks OR double sickening) and treatment (selection of amoxicillin with or without clavulanate, 
watchful waiting, or alternative treatment if indicated, and dose of antibiotic). Unconcordant care 
was defined as antibiotic prescription without documentation of concordant symptoms, timing, 
indication for alternative antibiotic to first-line treatment, or duration of dose.  
Information was collected on a chart audit tool (Appendix E) and transcribed into excel 
and SPSS.  Information collected on the chart audit tool also included data related to PQRS 
quality measures: PQRS #331 (when to prescribe an antibiotic for acute sinusitis) and #332 
(what antibiotic to select).  The baseline chart audit represents the tracking and reporting element 
of stewardship.   
Pre-test provider knowledge survey.  The pre-test provider knowledge survey (Appendix 
F) occurred during the first five minutes of the ASP and focus group session. Prior to the 
education session, participants were asked to complete the pre-test survey.  All surveys were 
voluntary, de-identified, and provided to non-resident primary care providers.  The pre-and post-
provider knowledge surveys (Appendix F, G) were created by the PI and based on the quality 
measures PQRS #331 and #332.  The survey consisted of 6 items and contained a combination of 
multiple choice and free text.  Questions one and two asked if providers had prior awareness of 
PQRS measures #331 and #332 respectively; questions three through six were pertinent to the 
PQRS measure content for symptoms and treatment.  Each of the four pertinent PQRS questions 
was weighted to account for 25% of the score, with a total of 100%.  Pre-and post-provider 
knowledge surveys were identical.  A total sample of 11 providers completed the pre-test and 
were present for the ASP.  The anonymous surveys were completed by hand and collected in 
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person.  No identifying information or demographics were collected on providers.  Survey 
responses were transcribed into excel and SPSS.   
Phase 2.  
Antimicrobial stewardship program and focus group.  A total sample of 11 providers 
participated in the ASP and focus group.  The education based ASP was an evidence based power 
point presentation developed by the PI using evidence review, including CDC fact sheet and 
reviewed by her clinical mentor.  Presented by the PI, the ASP covered: purpose, aims, and 
background of antibiotic stewardship, along with the PQRS sinusitis measure group.  The focus 
group was structured on the Health Belief Model and facilitated discussion on perceived 
susceptibility, severity, benefits and barriers to guideline recommended management of adult 
acute sinusitis.  The ASP with focus group lasted 30 minutes.  The ASP represents the education 
element of stewardship.    
Phase 3. 
Post-test provider knowledge surveys.  Post-test provider knowledge surveys were 
delivered one week after delivery of the ASP.  Surveys were distributed to all non-resident 
providers electronically via e-mail from the clinic manager.  The e-mail contained links to the 
REDCap survey with survey cover letter informing participants consent was indicated by 
voluntary completion of the surveys.  All surveys were voluntary, de-identified and provided to 
non-resident primary care providers.  Data was organized in excel spread sheets.   
Post-test chart audit.  The post-test chart audit was not feasible to complete due to time 
restrictions.  The goal for the post-test chart audit was a time-matched sample with the sample 
patient inclusion criteria, to be performed after the ASP.  The same chart audit tool and variables 
were to be collected.   
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Data analysis  
Descriptive statistics, including frequency distributions, means (M), and standard 
deviation (SD) were used to describe patients’ demographic characteristics.  Continuous 
variables were compared using the Independent Sample t-tests. For categorical variables, the chi-
squared test for independent samples was used, or Fishers exact test if values were less than 5 in 
any cell. All was analyses were conducted using SPSS version 22; an [alpha] level of .05 was 
used for statistical significance throughout. 
Results 
Participants  
Providers. Clinic demographics include: 21 physicians, 6 advanced practice registered 
nurses, and 1 physician’s assistant.  Resident providers were not included to maximize 
homogeneity over time.  A convenience sample of 11 eligible providers were present and 
consented to participation in the ASP.  An additional 17 providers did not attend the luncheon 
and could not be included.  A total of 11 providers completed the pre-survey and 9 of these 11 
completed the post-survey.  No demographics were measured in order to protect anonymity in 
this small sample. All of respondents of the post-test survey reported they completed the pre-test 
and ASP, as indicated by a yes/no question and the of the post-test survey.   
 Patients.  The total sample size of the group of patients identified for the chart audit 
consisted of 22 patients.  Patient demographics are displayed in Table 1.  The sample included: 4 
males and 18 females, ages ranging from 19 to 74 (M = 49.14, SD = 15.72); 18 white, 4 non-
white, and 14 participants had private insurance, 2 had Medicare, and 6 had Medicaid.  There 
were no significant differences in gender, age, race or insurance and the delivery of guideline 
concordant care or unconcordant care defined as documentation of: correct symptoms (purulent 
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nasal drainage with or without facial pain and nasal obstruction), for the correct duration of time 
(10 days to 4 weeks OR double sickening) and antibiotic selection (amoxicillin with or without 
clavulanate, watchful waiting, or alternative treatment if indicated).    
Phase 1 
Baseline assessment.  Medical records from the sample of 22 patients at the internal 
medicine clinic with acute sinusitis ICD codes (J01.00, J01.10, J01.20, J01.30, J01.40, J01.80, 
J01.90) were analyzed based on demographics, symptoms, duration of symptoms, antibiotic 
selection, and dose (described in Figure 1). Evaluation of group differences in demographic 
variables between patients receiving concord and unconcordant care was conducted and no 
significant differences were found (Table 1).   
Care Components. Care components assessed in the chart audits included documentation 
of: Symptoms, timing, and treatment (antibiotic and dose).  Concordant treatment consists of 
appropriate symptoms, timing, antibiotic selection and dose duration.  See figure 1. 
Care concordant with the PQRS measures was delivered 59.09% of the time (n=13). This 
includes 8 patients who received concordant antibiotics, and 5 who appropriately did not receive 
antibiotics.  Concordant symptoms were documented in 72.7% (n=16) of patients; concordant 
timing of symptoms was documented in 50% (n=11) of patients, and concordant antibiotic 
prescription was documented in 47.1% (n=8) of cases.  Figure 1 shows the distribution of 
patients among care components.  
Table 2 further presents distribution of adherence to individual care components between 
concordant and unconcordant care.  Timing significantly differed between concordant and 
unconcordant care (90.1% vs. 9.1%, P=.009*).   
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Antibiotic use. Antibiotics were prescribed in 77.3% of cases (n=17), of those 17 cases, 
41% (n =8) were Amoxicillin with or without clavulanate, 29.4% (n =5) were macrolides, 17.6% 
(n = 3) were levofloxacin, and 11.8% (n=2) were doxycycline. Antibiotics were prescribed 
concordantly with PQRS measures 47.1% (n=8) of the time, 52.9% (n=9) were not.  Of the non-
concordant antibiotics prescribed, 88.9% (n=8) were unnecessary, and 11.1% (n=1) were for a 
dose longer than recommended.   
 Frequency of antibiotic selection was similar between concordant and unconcordant care 
(Table 2).  There were no significant differences between groups receiving concordant vs. 
unconcordant care across the following variables: receiving an antibiotic prescription (23.1% vs. 
22.2%, P= .855), receiving Amoxicillin with or without clavulanate (38.5% vs. 22.2%, P =.735), 
receiving a macrolide (15.4% vs. 33.3%, P = .683), receiving levofloxacin (15.4% vs. 11.1%, P 
>.999), and receiving doxycycline (7.7% vs. 11.1%. P>.999).  Though not statistically 
significant, it is important to note amoxicillin with or without clavulanate was prescribed at a 
higher rate in the concordant group (38.5% vs. 22.2%, P =.735), while macrolides were 
prescribed at a higher rate in the unconcordant group (15.4% vs. 33.3%, P = .683).  
First line antibiotics (amoxicillin with or without clavulanate) were prescribed 41% (n=8) 
of the time, though only 71.4% (n=5) of these were included in concordant care.  The remaining 
28.6% (n=3) were prescribed to patients who did not have concordant symptoms documented for 
the recommended duration; and thus were deemed unnecessary based on PQRS criteria? .  Of all 
non-first line recommended antibiotics, 100% (n=12) had a documented indication for an 
alternative antibiotic treatment.  The PQRS measures do not provide a recommended second line 
treatment, but require documentation of an indication for an alternative.  Given the parameter of 
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first line treatment or documentation of an indication for an alternative with no second-line 
treatment suggestions, 100% (n=17) of the antibiotics were selected appropriately. 
 Pre-test provider knowledge survey.  A total of 11 providers participated in the pre-test 
provider knowledge survey.  The overall mean score for the provider knowledge survey was 
52.27% (SD = 26.11) out of 100%.  A score of roughly 50% indicates that on average providers 
correctly answered two out of four questions on the survey.  Within the pre-test provider 
knowledge survey, 27.3% (n=3) providers were aware of PQRS measures #331 and #332.  The 
frequency of identification of correct answers is as follows: diagnostic symptoms, 63.6% (n=7); 
duration of symptoms, 45.5% (n=5); first line antibiotic, 27.3% (n=3), and indication for 
alternative antibiotic, 72.7% (n=8) (see Table 3).  
Phase 2 
 Phase two consisted of the educational ASP and focus group.  A total of 11 providers 
participated in the ASP and focus group.  The ASP was a power point presentation which 
covered: purpose, aims, background antibiotic stewardship, and PQRS sinusitis measure group.  
Following the ASP, the focus group was structured on the Health Belief Model and designed to 
allow for discussion on perceived susceptibility, severity, benefits and barriers to guideline 
recommended management of adult acute sinusitis.  The ASP with focus group lasted 30 
minutes.   
 During the focus group, providers reported barriers to practice included: lack of time, 
pressure from patients, and lack of understanding from patients.  Providers also reported that 
support in appropriate antibiotic timing, and support in educating patients on symptom 
management would help overcome the barriers to appropriate prescribing.  Providers also gave 
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positive feedback about the program as evidenced by parting statements of appreciation and 
stating they were glad this specific need had been recognized.   
Phase 3 
 Post-Test Provider knowledge surveys.  A total of nine providers completed the post-test 
provider knowledge survey.  All post-test responders indicated they completed the pre-test, per a 
yes/no question at the end of survey.  The overall mean score for the post-test was 55.56% (SD = 
24.30).  An overall score of 55.56% still indicates roughly answering two out of four questions 
correctly.  Within the post-test provider knowledge survey, 66.7% (n=6) providers were aware of 
PQRS measures #331 and #332.  The frequency of identification of correct answers is as follows: 
diagnostic symptoms, 33.3% (n=3); first line antibiotic, 33.3% (n=3), duration of symptoms, 
55.5% (n=5); and indication for alternative, 100% (n=9).  An independent-sample t-test was 
conducted to compare the overall provider survey score for pre-and post-tests.  The post-test 
mean is higher than the pre-test, indicating gained knowledge from the ASP.   However, there 
was no significant difference in scores between the pre-test (M = 52.27, SD =26.11) and post-test 
(M = 55.56, SD = 24.30; t (18) = -.288, p = .776, two-tailed).   There were no significant 
differences between frequency of correct answers on individual questions between pre-and post-
surveys.  Scores increased for all questions except the question on sinusitis symptoms (63.6% vs. 
33.3%) (Table 4). 
 Practice vs. knowledge.  
Frequencies of concordant care found in the chart audit and corresponding survey 
questions were compared to examine provider practice alongside provider knowledge.  No 
statistical comparison could be made between documentation practices (as determined by the 
chart audit) and knowledge (as determined by provider surveys) because the surveys were 
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anonymous and no tracking occurred (Table 5).   Per the chart audit, providers performed better 
on symptom documentation than on the pre-and post-provider knowledge survey (77.3% vs. 
63.6% vs. 33.3%) and alternative indication documentation (100% vs. 72.7% vs. 100%).  
Concordant documentation and correct answers on timing and first line antibiotic selection as 
similar between all three measures.   
Post-Test chart audit.  No data for the post-test chart audit and comparison was collected 
due to time restriction.  Data to be collected was identical to the baseline chart audit.  Collecting 
the same data would have allowed for comparison of prescribing behavior before and after ASP 
to assess for changes.   
Discussion   
Findings from this descriptive study indicate that the majority of sinusitis cases treated by 
providers in this internal medicine clinic were consistent per PQRS measures #331 and #332 
[59.1% (n=13)].  However, among patients who received antibiotics, 47.1% of all antibiotics 
prescribed were unnecessary and for 52.9% of the patients who received an antibiotic, the choice 
of antibiotic prescribed was inappropriate.  Among these inappropriate choices, 88.9% of were 
deemed unnecessary because of an inadequate duration of symptoms at the time of prescription.  
Secondly, the ASP was well received and in general mean knowledge scores increased from pre-
to post-test. The major findings of this study are consistent with previous research that identified 
timing as key component related to inappropriate antimicrobial prescribing (Pynonnen et al, 
2015) and similar rates and frequencies compared to national averages for adult acute sinusitis 
(Fairlie et al, 2012), and that communication and education support are important provider 
perceived barriers than need to be addressed perceived provider barriers (Dempsey et al., 2014).  
Further discussion of findings are presented in the following sections.   
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Antibiotic Timing  
In this study prescribing an antibiotic too early was the most likely reason for antibiotic 
prescriptions to be unconcordant.  Antibiotic timing was statistically significantly different 
between concordant and unconcordant care (90.9% vs. 9.1%, P= .009).  This is also consistent 
with Pyonnen who found antibiotics were frequently prescribed too early in the disease course 
(Pynnonen et al., 2015).    Antibiotics prescribed outside of the time frame are considered 
unnecessary because the patient does not meet the diagnostic criteria for acute sinusitis; these 
findings are consistent with national trends of over prescribing antibiotics for acute sinusitis 
because they are unnecessary (Fairlie et al, 2012; Rosenfeld et al., 2015).   
Patients seeking an antibiotic too early is also consistent with barriers to guideline 
recommended care as reported by providers in this study.  This study and other qualitative 
studies (Dempsey, 2014) report patient expectations for receiving an antibiotic prescription and 
lack of knowledge realted to when antibiotics should be prescribed as barriers to delivering 
guideline recommended care.  Educating patients on the importance of correct timing for 
treatment is a clear education opportunity for primary care providers and healthcare workers.  
Successful education would help empower patients to manage symptoms, make environmental 
modifications, decrease health care visits, and decrease unnecessary antibiotics.   
Antibiotic Selection 
  In addition to timing, class of antibiotics prescribed was assessed.  Antibiotic prescribing 
trends are presented in figure 2 and are compared to national practice rates.  No statistical 
comparison could be made between the National Trend and internal medicine clinic because 
sample sizes were not provided by researchers Fairlie et al., 2012 in their analysis of the 
NAMCS and NHAMCS data between 2000 and 2009. Overall, in this small sample the internal 
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medicine clinic appears to have lower rates of overall antibiotic prescribing (77.3% vs. 83%), 
indicating less unnecessary antibiotics; and higher rates of selecting the first line antibiotic 
Amoxicillin with or without Clavulanate (41% vs. 33%).  The trend of less unnecessary 
antibiotics and more appropriate first line antibiotics could be due to provider preference, 
inclusion of resident providers within the chart audit, cost, and time.  A recent study on sinusitis 
prescribing patterns found resident and student providers have better antibiotic prescribing rates 
than experienced providers (Pynnonen et al., 2015), it is possible that integration of resident with 
attending providers in this clinic lead to fewer unnecessary and more appropriate antibiotics than 
the national trend, which may be unique characteristics with academic medical centers. 
As previously described in the results, antibiotics were prescribed concordantly with 
PQRS measures 47.1% (n=8) of the time.  Of the 52.9% (n=9) of antibiotics not prescribed 
concordantly with the PQRS measures, 88.9% (n=8) were prescribed before 10 days of 
symptoms without the presence of double sickening, indicating they were unnecessary.  The 
remaining 11.1% (n=1) of inappropriate antibiotic prescriptions was prescribed for 21 days, 
greater than the recommended 5-10 days.  First line antibiotics were selected 41% (n=7) of the 
time.  All cases with a non-first line treatment, including macrolides, had a documented 
indication for an alternative treatment.  This indicates 100% (n=17) of antibiotics were selected 
appropriately per the PQRS quality measures.   
Although the PQRS measures #331 and #332 do not provide a recommendation for 
second line treatment (PQRS, 2016), the CDC recommends second line treatment as 
Doxycycline or Levaquin, and to avoid macrolides (CDC, 2016).  In this sample, macrolides 
were prescribed in 29.4% (n = 5) of cases.   If the PQRS adapts the CDC’s recommendation to 
avoid macrolides, then the rate of inappropriate antibiotics would increase from 11.1% (n=1) to 
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35.3% (n=6).  Of the inappropriate antibiotics, 83.3% (n=5) would be due to the selection of a 
macrolide as second-line treatment. Understanding discrepancies between guideline 
recommended care and quality measure care will be helpful in anticipating future changes to 
quality measures, as well as provide a deeper understanding of prescribing patterns.  This reflects 
an evolution of science and the translation of knowledge into practice since the PQRS measure 
were published prior to the CDC recommendations.  The CDC’s recommendations represent the 
latest evidence.  Though understanding current quality measures used by institutions is important 
for standard practice, providers should also be aware of current evidence based practice to ensure 
best practice  
Lack of clear national benchmarks for antibiotic prescribing may be a factor in 
prescribing practices because it makes progress difficult to measure.  The White House National 
Action Plan (2015) reported a goal of decreasing unnecessary antibiotics by 50% by the year 
2020.  The CDC reports over 30% of antibiotics are unnecessary (CDC,2016).  While decreasing 
unnecessary antibiotics by 50% by the year 2020 appears clear, to accurately measure a decrease 
in unnecessary antibiotics, specific information on rates of unnecessary antibiotics are needed.  
Understanding unnecessary antibiotic use requires more detailed reporting of antibiotic use and 
clinical variables related to drug use.   
  In this study, macrolides were prescribed at similar rates between this sample size and the 
national trend (Fairlie et al, 2012).  In addition to being costly (Cramer et al, 2016) macrolides 
have a lower efficacy rates for treating sinusitis (Anon et al., 2004) and higher rates of resistance 
(IDSA, 2012).  However, providers may be more likely to choose azithromycin because of a 
shorter dose duration (5 vs 10 days), dosing (daily vs BID) and less frequent gastrointestinal side 
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effects compared to Augmentin (RxList, n.d.).  Education to providers and patients should 
include emphasis on the cost, lack of efficacy, and resistance related to macrolide use.  
ASP and focus group. 
 The ASP was created based on PQRS measures #331 and #332 and CDC’s (2016) 
recommendations for diagnosis and treatment of acute sinusitis and presents the education 
element of the CDC’s core elements of outpatient stewardship (CDC, 2016).  A total of 11 
providers participated in the ASP and focus group and it was well received.  Though the sample 
was too small to definitively assess a statistical difference between the pre-and post-surveys, , the 
increase in mean scores suggests the ASP was effective in increasing knowledge  
   During the focus group, providers reported lack of time, pressure from patients, and lack 
of understanding from patients as barriers to prescribing antibiotics per the PQRS 
recommendations.   Providers also reported interest in support for appropriate antibiotic timing 
and patient education.  Barriers expressed by providers in this study are similar to barriers found 
in a recent qualitative survey of primary care providers by Dempsey and colleagues (2014) who 
identified the following perceived barriers to appropriate antibiotic prescribing as: (a) patient 
demand; (b) lack of accountability; (c) time and money saving; (d) treatment misconceptions; (e) 
diagnostic uncertainty; and (f) fear of patient dissatisfaction.    
 Future education based ASPs could benefit from multidisciplinary collaboration (Arnold 
et al, 2004), serial sessions, and inclusion of web-based modules or other active education 
techniques (Ranji Steinman, Shjojania & Gonzales, 2008), communication training (Drekonja, 
Filice, Greer & Olson 2015; van der Velden et al, 2012) and electronic clinical decision support 
(McDonagh et al, 2016).  These techniques are all endorsed by the CDC’s Get Smart, Know 
When Antibiotic’s Work Campaign (CDC, 2016). In this focus group providers agreed that their 
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biggest barrier was communication with patients regarding when antibiotics are appropriate.  An 
effective strategy to address this would be communication training, which involves patient 
education on appropriate antibiotic use.  This strategy would address reported perceived barriers 
to guideline recommended care, and has been shown to decrease overall antibiotic prescribing 
rates (Drekonja et al., 2015).  
Though the key systematic reviews cited by the CDC have mixed conclusions on the 
effect of various stewardship program components and approaches, each review which examined 
communication skills training for patient interactions found significant reduction in overall 
number of antibiotics prescribed (CDC, 2017) Further research on identifying influential 
provider and patient factors is needed.  Possible provider factors include years of experience, 
area of specialty, and location of practice.  Patient factors may be level of education, access to 
follow up care, age, and possible comorbidities.  Influential factors and specific ways to combat 
these factors   are needed to effectively overcome barriers to providing guideline recommended 
care This need has been identified by similar studies (Pynnonen et al., 2015) and was confirmed 
by the focus group in this study.   
 The focus group was held immediately after the ASP which was held during a scheduled 
lunch hour.  The scheduled time may have limited participation and attention of providers due to 
the session occurring during a lunch period in the middle of a clinic day.  Providers could have 
been distracted by clinical issues and eating in a timely fashion.  Separating the focus group and 
ASP may have allowed for increased participation by allowing time to process ASP content 
without usurping a lunch hour. 
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Pre-test/posttest. 
A total of 11 providers participated in the pre-test survey; and nine in the post-test survey.  
All nine of the respondents from the post-test complete d the pre-test.  Overall trend of mean 
provider scores improved from pre-test (M = 52.27, SD =26.11) to post test (M = 55.56, SD = 
24.30; t (18) = -.288, p = .776, two-tailed)., though not significantly.  This is consistent with a 
Cochrane review conducted by Arnold et al (2004) which reported only minor and observational 
changes occurred after a single intervention; at this point in the ASP, providers had only received 
the education component of the ASP, and no baseline chart audit with feedback had been 
conducted.  Scores increased for all questions pre-test to post-test except the question asking 
about key symptoms (Table 5).  Providers were able to identify fewer symptoms on the post-test. 
Possible explanations include: the ASP and or question were not clear or valid measures of 
knowledge, provider apathy, lack of clinical content for the survey question, and continued 
influence effect from prior knowledge. Further inquiry via focus group is warranted to further 
explore possible explanations. 
 Practice vs. knowledge.    
 Provider practice in general appeared to be similar or better than perceived provider 
knowledge (Table 5).  There are several possible reasons for this, though understanding them 
definitively is not within the scope of this project.  The clinical context of practice may act as a 
cue to action for providers, allowing them to recognize clusters of symptoms more effectively 
than to generate a list of symptoms on demand.  The chart audit contained a random selection of 
all providers, which could have captured a more accurate representation of the provider 
knowledge base.  Documentation is a representation of knowledge, and so may be a more valid 
form of understanding provider knowledge than a survey.   
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Limitations 
 A key limitation to this study was the small sample size for the baseline chart audit and 
the provider knowledge surveys.  The samples were too small to determine meaningful statistical 
significance.  The goal sample size was 120, however because of the sampling issues previously 
discussed, the total sample for this study was only 22.  It is possible the data was difficult to 
mine with the given inclusion criteria, creating what appeared to be a large sample size.  
Including all ICD-10 codes may have been too broad.  Future studies should work with CCTS to 
better define criteria for an improved sample.  Narrowing down to the most frequently used 
codes for acute sinusitis may have ensured patients selected would have the appropriate 
diagnosis. Because many patients excluded were pediatric and ineligible, raising the age for 
inclusion to 19 would ensure patients were 18 through the entire year of sampling, decreasing 
possible pediatric patients.   
Timing of the ASP and chart audit are an additional limitation.  Initially, the ASP and 
baseline chart audit were designed to occur during the late fall.  Due to external circumstances, 
the time frame was adjusted to the late spring with the hopes of completing a time-matched post-
ASP chart audit.  The post-ASP was not able to be completed, which unfortunately resulted in a 
short time period for the baseline chart audit.   In future studies, a broader period will be 
requested in IRB applications to cover both fall and spring for inclusion of the influenza season 
and to have a large pool of sinusitis cases from which to randomly select.   
Research on outpatient stewardship has been ongoing during the development of this 
project.   Key resources published by the CDC’s Get Smart Campaign (CDC, 2016) were not all 
available at the time of the project development, and should be included in future ASPs.  
Continued research to standardize and validate education based ASPs and provider knowledge 
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surveys is needed, along with more detailed tool kits to develop and implement stewardship 
programs.  Standard and validated ASPs and provider knowledge surveys would allow for larger 
scale tracking of clinical, provider and population based data when combined with NAMCS and 
NHAMCS 
Practice Improvement Recommendations 
 General recommendations for outpatient stewardship improvement are for all outpatient 
clinics to embrace the CDC’s four elements of outpatient stewardship of commitment, action, 
tracking and reporting, and education and expertise (CDC, 2017).  Providers and practices 
should: 
• Commit to improving antimicrobial stewardship to decrease antimicrobial 
resistance, adverse drug effects, and to improve patient outcomes.   
• Act to support antimicrobial stewardship practice policies on administrative, 
research, and practice levels.   
• Track and report antibiotic use and resistance rates to understand personal, 
clinic, and health care system prescribing and resistance patterns.   
• Educate and seek expertise on current practice guidelines, policy, and 
stewardship practices.   
Specific recommendations for improving antibiotic stewardship for sinusitis in the 
internal medicine clinic evaluated in this project are for providers to commit to PQRS measure 
#331 and #332 along with the CDC’s second line treatment recommendations for the diagnosis 
and treatment of acute sinusitis as a standard of practice (PQRS, 2016; CDC, 2017).   
Commitment should occur through engaged partnership through the CDC’s Get Smart 
Campaign (CDC, 2016) active audits of provider prescribing, use of posters, and public health 
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lectures for patients on acute sinusitis.  Audits should be published to all providers in the clinic to 
increase peer accountability (Meeker et al, 2016).  Providers should act by clearly documenting 
indications for selecting second line antimicrobial therapy.  Administration should endorse a no-
macrolide policy for the treatment of acute sinusitis unless all alternative treatments are 
contraindicated (CDC, 2016).  The clinic should track and report antibiotic frequencies and 
allow for peer to peer comparison of rates (CDC, 2017).  Finally, the clinic should collaborate 
with pharmacy and infectious disease to develop multidisciplinary active education for providers 
and patients on treatment guidelines and symptom management.  Patient education should 
include posters and printed material.  Provider education should be free of charge and web based 
to be taken at provider’s convenience (CDC, 2017) 
Further Investigation 
Project continuation.   Further work should begin with establishing a more 
representative baseline chart audit, and modifying the ASP to address limitation as previously 
discussed.   Creating a new baseline chart audit should obtain the desired sample of 103 
randomly selected patients in this clinic.  The chart audit should occur over the course of an 
entire calendar year.  A time-matched post ASP chart audit should be performed to assess for any 
impact of the ASP as evidenced by changes in provider prescribing behavior.  Once the ASP is 
deemed effective in this site, it should be expanded to all primary care clinics in this healthcare 
system.  
The ASP should be developed with a multidisciplinary team and include the CDC’s Get 
Smart About Antibiotic’s printed materials.  Partnership with the CDC provides clinics and 
clinicians with additional resources for stewardship.  Education should be provided to patients 
and providers.  Provider education should be multiple sessions, active, and should remain free of 
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charge.  Emphasis on the provider education should be on ways to communicate with patients 
who expect an antibiotic, the importance of appropriate diagnostic criteria, first and second-line 
treatment, and timing for treatment.  Collaboration with administration and information 
technology to investigate the possibility of an electronic medical record decision support tools 
such as hard stop for non-first line antibiotic selection justification should be discussed.  Patient 
education should be provided during acute sinusitis visits and should be documented in the plan.   
Outpatient stewardship.  Future studies on outpatient stewardship should continue 
examine the effectiveness of different techniques to modify provider prescribing behavior.  
Education, peer accountability, electronic decision support tools and accountable justification 
techniques have all been shown to decrease overall and unnecessary antibiotic prescribing, 
though to varying degrees (CDC, 2016).  Increased understanding of the effectiveness of 
different interventions would help to improve stewardship (CDC, 2017).  Knowledge on 
intervention effectiveness should be included in a more specific outpatient stewardship tool kit, 
which clinics and providers could implement for multiple disease processes.  Additional research 
is needed on identifying the most meaningful data to track for prescribing behavior and 
resistance.  Finally, research is needed on effective ways to modify patient expectations for 
treatment (CDC, 2017; Dellit et al, 2007).  Providers identified patient expectations and pressure 
for antibiotics as a key barrier to the delivery of guideline recommended care.  Furthermore, 
research has shown that patient education sessions are also effective techniques at reducing 
overall antibiotic prescribing rates (McDonagh, et al, 2016). An effective patient education arm 
to the ASP would be helpful for this clinic.   
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Conclusion 
Antimicrobial stewardship is a multidisciplinary practice to improve antimicrobial 
prescribing to improve patient outcomes, decrease adverse drug effects, and decrease costs 
through adherence to clinical practice guidelines to promote appropriate treatment while 
decreasing microbial resistance (CDC, 2016; Dellit et al, 2007).  Antimicrobial stewardship 
programs are multi-disciplinary programs designed to improve judicious use of antibiotics This 
study was an education based antimicrobial stewardship program designed to assess current 
provider prescribing behavior and knowledge and provide education on PQRS measures #331 
and #332 to promote guideline adherent care.  While the sample sizes were too small to 
definitively state any meaningful statistical significance, the chart audit suggests the majority of 
sinusitis cases are treated per PQRS guidelines [59.1% (n=13)].  However, the majority of 
antibiotics were not prescribed concordantly [52.9% (n=9)].  The lowest scoring components of 
treatment include timing and antibiotic selection [50% (n=11)].  When care was non-adherent, 
the most likely factor was time, p=.009* 
The provider knowledge survey results suggest knowledge increased after the ASP; pre 
(M = 52.27, SD =26.11); post (M = 55.56, SD = 24.30; t (18) = -.288, p = .776, two-tailed).  The 
decrease score on the symptom questions suggests the ASP needs clarity on symptomology.  
Finally, when comparing the provider knowledge surveys to the chart audit, it appears that 
provider knowledge and practices are overall similar.   
Further investigation is needed on the most effective strategies to improve outpatient 
stewardship practices for providers and patients. Evidence based strategies for further 
investigation have been provided in the discussion.  Increased knowledge on effective outpatient 
stewardship may help improve results of similarly designed studies, and overall improve patient 
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outcomes through increased antibiotic stewardship for acute sinusitis and additional outpatient 
diagnoses.   
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Table 1 
Demographics between concordant and unconcordant care.    
 
     
Variable Total Concordant Unconcordant Significance  
Age (m, sd) 49.1 (15.7) 54.9 (8.9) 45.2 (18.4) P=.16 
Gender % (n)       P >.999 
Male 18.2 (4) 50 (2) 50 (2)   
Female 81.8 (18) 61.1 (11) 38.9 (7)   
Race (%)       P>.999 
White 81.8 (18) 61.1 (11) 38.9 (7)   
Non-White 18.2 (4) 50 (2) 50 (2)   
Insurance (%)       P=.367 
Private 63.6 (14) 50 (7) 50 (7)   
Medicare 9.1 (2) 100 (2) 0 (0)   
Medicaid 27.3 (6) 66.7 (4) 33.3 (2)   
Table 1     
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Table 2 
Distribution of adherence to individual components of PQRS guidelines; Concordant Care vs. 
Unconcordant Care %, ( n) 
  Total 
N=22 
Concordant 
n=13 
Unconcordant 
n=9 
Significance  
P= 
Symptoms 72.3 (16) 56.3 (9) 43.8 (7) >.999 
Timing  50 (11) 90.9 (10) 9.1 (1) .009* 
Double 
Sickening 
4.6 (1) 100 (1) 0 (0) >.999 
Antibiotic 77.3 (17) 58.8 (10) 41.2 (7) >.999 
First Antibiotic 31.8 (7) 71.4 (5) 25.6 (2) .735 
Alternative  50 (11) 54.6 (6) 45.5 (5) >.999 
Dose  59.1 (15) 60 (9) 40 (6) >.999 
Table 2     
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   Table 3 
 Antibiotic use between concordant and unconcordant care.   
 Concordant Unconcordant Significance 
 n=13 n=9 P= 
No antibiotic 23.1 (3) 22.2 (2) .855 
Amoxicillin with or 
without Clavulanate 
38.5 (5) 22.2 (2) .735 
Z-pack 15.4 (2) 33.3 (3) .683 
Levofloxacin 15.4 (2) 11.1 (1) >.999 
Doxycycline  7.7 (1) 11.1(1) >.999 
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Table 4 
Provider Knowledge Survey Scores; Frequency of correct scoring on individual components 
between pre-and post-test 
 % (n) Pre 
N=11 
Post 
N=9 
Trend Significance 
P=  
Total 52.27 55.56 ↑ .776 
Are you aware of PQRS measure #331? 27.3 (3) 66.7 (6) ↑ .190 
Are you aware of PQRS measure #332? 27.3 (3) 66.7 (6) ↑ .190 
What are the symptoms of acute sinusitis? 63.6 (7) 33.3 (3) ↓ .369 
How many days after sinusitis symptom onset 
are antibiotics appropriate?  
45.5 (5) 55.5 (5) ↑ >.99 
What is the first line antibiotic(s) of choice? 27.3 (3) 33.3 (3) ↑ >.99 
What are at least three indications to not use 
the first line antibiotic of choice? 
72.7 (8) 100 (9) ↑ .285 
Table 4     
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Table 5 
Frequencies of concordant care per Chart Audit vs. Correct answers on pre-and post-test 
surveys 
  Chart Audit 
% (n) 
N=22 
Survey, Pre 
% (n) 
N=11 
Survey, Post 
% (n) 
N=9 
Symptoms 77.27 (16) 63.6 (7) 33.3 (3) 
Timing 54.6 (12) 45.4 (5) 55.5 (5) 
First-Line Antibiotics 31.8 (7) 27.3 (3) 33.3 (3) 
Alternative Indication 40.91 (9) 72.7 (8) 100 (9) 
Dose 68.2 (15) n/a n/a 
Table 5    
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Figure 1.  Distribution of care components  
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Figure 2. Proportions of antibiotics prescribed for acute sinusitis, National trends vs. UK 
HealthCare General Internal Medicine & Geriatrics 
 
 
 
 
(Fairlie, Shapiro, Hersh & Hicks, 2012)  
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Appendix A 
Form F 
Educational Intervention Cover Letter 
 
To : UK General Internal Medicine and Geriatrics Providers:  
The purpose of the study is to align antibiotic prescribing for adults with acute sinusitis with 
PQRS measures #331 and #332 through: a) Assess current antibiotic prescribing patterns and 
provider knowledge for acute sinusitis in adult patients, b), develop and implement an education 
and evidence based ASP based on PQRS measures #331 and #332, and c) Evaluate provider 
knowledge and practices before after ASP implementation to assess effect of ASP as evidenced 
by changes in antibiotic prescribing and provider knowledge.   
Although you will not get personal benefit from taking part in this research study, your 
participation in the education session may offer meaningful insight to PQRS measurement 
standards for the treatment of acute sinusitis.  Minimal risks and discomforts are expected to be 
associated with participation in this study.  Benefits to participation include contributing to 
knowledge of antibiotic prescribing patterns for adults with acute sinusitis and increased 
knowledge of PQRS measurement standards associated with CMS reimbursement.   
 
 
There are no known risks to participating in this study.  
 
IF ANONYMOUS: Your participation in this study is anonymous which means no names 
will appear or be used on research documents, or be used in presentations or publications.  The 
research team will not know that any information you provided came from you, nor even 
whether you participated in the study.  
 
Please be aware, while we make every effort to safeguard your data once received on 
our servers via REDCap, given the nature of online surveys, as with anything involving the 
Internet, we can never guarantee the confidentiality of the data while still en route to us. 
 
If you have questions about the study, please feel free to ask; my contact information is 
given below.  If you have complaints, suggestions, or questions about your rights as a research 
volunteer, contact the staff in the University of Kentucky Office of Research Integrity at 859-257-
9428 or toll-free at 1-866-400-9428. 
 
Thank you in advance for your assistance with this important project.   
Sincerely, 
 
Katelyn Hellman  
College of Nursing, University of Kentucky 
PHONE:  616-881-9974 
E-MAIL:  kmde222@uky.edu 
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Appendix B 
Consent to Participate in a Research Study  
Adult Acute Sinusitis Antimicrobial Stewardship Program in a Primary Care Setting 
WHY ARE YOU BEING INVITED TO TAKE PART IN THIS RESEARCH? 
You are being invited to take part in a research study about antibiotic prescribing for adults with 
acute sinusitis. You are being invited to take part in this research study primary care providers are likely to 
treat patients for acute sinusitis, which is the most common acute respiratory tract infection seen in the 
primary care setting.  If you volunteer to take part in this study, you will be one of about 30 people to do 
so. 
WHO IS DOING THE STUDY? 
The person in charge of this study is Katelyn Hellman, RN, BSN, DNP(c) of University of 
Kentucky, Department of College of Nursing.  Ms. Hellman is a doctoral student and is being advised by 
Dr. Elizabeth Tovar.  There may be other people on the research team assisting at different times during 
the study.  
 
WHAT IS THE PURPOSE OF THIS STUDY? 
The purpose of this study is to align antibiotic prescribing for adults with acute sinusitis with PQRS 
measures #331 and #332 though: a) Assessment of current antibiotic prescribing patterns and provider 
knowledge for acute sinusitis in adult patients, b) Develop and implement an education and evidence 
based ASP based on PQRS measures #331 and #332, and c) Evaluate provider knowledge and practices 
before after ASP implementation to assess effect of ASP as evidenced by changes in antibiotic prescribing 
and provider knowledge.   
 
By doing this study, we hope to learn current antibiotic prescribing patterns for adults with acute 
sinusitis, provider knowledge of PQRS measures #331 and #332, and the impact of a brief educational 
intervention.   
ARE THERE REASONS WHY YOU SHOULD NOT TAKE PART IN THIS STUDY? 
There are no known reasons why you should not participate in the educational intervention.  
Participation in one aspect of this study does not mandate or preclude participation in the other aspects of 
this study.  Resident physicians will not be invited to participate in the follow-up survey to help ensure a 
consistent sample of providers.   
WHERE IS THE STUDY GOING TO TAKE PLACE AND HOW LONG WILL IT LAST?  
The research procedures will be conducted at UK General Internal Medicine and Geriatrics.  You 
will need to come to the staff meeting ON ESTABLISHED DATE/TIME/LOCATION one time during the 
study.  The visit will take about 30 minutes.  The total amount of time you will be asked to volunteer for 
this study is 40 minutes over the next year for the remainder of the education session and a follow up 
survey.   
WHAT WILL YOU BE ASKED TO DO? 
As a participant, you will be asked to be present for an educational intervention on PQRS 
measures #331 and #332.  The PI will be collecting data on antibiotic prescribing behavior before and 
after the intervention.  No consequences will occur for choosing to not participate, to withdrawal, or to use 
individual clinical judgement in treatment of adults with acute sinusitis. 
Time-line: 
1. October- November 2015: provider knowledge survey followed by education intervention  
2. October or November and consecutive four months thereafter: retrospective chart audit for 
antibiotic prescribing behavior from first business day after the education intervention and 
consecutive four months, backdated 1 year.   
3. April -May 2017: post-assessment chart audit for antibiotic prescribing behavior from first 
business day after provider education intervention to four months thereafter; post-assessment 
provider knowledge survey to be distributed the first Monday after completion of the four-month 
chart audit time period.   
WHAT ARE THE POSSIBLE RISKS AND DISCOMFORTS? 
Potential risks and discomforts include: violating confidentiality for patient and provider 
participants, embarrassment, frustration and negative evaluation.  The PI has attempted to minimize risk 
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by providing for patient and provider confidentiality and maintaining provider clinical decision making 
autonomy.  Education is supported by CMS through PQRS measures #331 and #332; provider autonomy 
in clinical decision making remains unchanged.  Participants may choose to withdraw from the study at 
any time.  No punitive or incentivized action will be taken against providers for sinusitis treatments.  If 
participants experience emotional distress from study participation, they can contact the PI for information 
regarding free psychological services offered to employees of the University of Kentucky. 
WILL YOU BENEFIT FROM TAKING PART IN THIS STUDY? 
There is no guarantee that you will get any benefit from taking part in this study.  You may have 
increased understanding of PQRS measures #331 and #332 after the educational intervention.  Your 
willingness to take part may (a) help the University of Kentucky better understand antibiotic use rates for 
acute sinusitis; and (b) help researchers understand effectiveness of educational antimicrobial 
stewardship interventions.   
DO YOU HAVE TO TAKE PART IN THE STUDY? 
If you decide to take part in the study, it should be because you really want to volunteer.  You will 
not lose any benefits or rights you would normally have if you choose not to volunteer.  You can stop at 
any time during the study and still keep the benefits and rights you had before volunteering.   
IF YOU DON’T WANT TO TAKE PART IN THE STUDY, ARE THERE OTHER CHOICES? 
If you do not want to be in the study, there are no other choices except not to take part in the 
study. 
 
WHAT WILL IT COST YOU TO PARTICIPATE? 
 
Costs for participating in this study include:  
• 10 minutes for pre-intervention survey completion 
• 30 minutes for education session 
• 10 minutes for post-intervention survey completion.   
WHO WILL SEE THE INFORMATION THAT YOU GIVE? 
Data collected will be stored electronically on a secure server through the college of nursing.  
Access to the database will be password protected.  The database can be accessed on the PI’s password 
protected encrypted laptop with VPN access.  Informed consent will be stored in Dr. Tovar’s locked office 
in a locked file cabinet.   
The education portion of this study is de-identified.  We will make every effort to keep confidential 
all research records that identify you to the extent allowed by law. 
Your information will be combined with information from other people taking part in the study. 
When we write about the study to share it with other researchers, we will write about the combined 
information we have gathered. You will not be personally identified in these written materials. We may 
publish the results of this study; however, we will keep your name and other identifying information 
private.  
We will make every effort to prevent anyone who is not on the research team from knowing that 
you gave us information, or what that information is.   
For the survey, “Please be aware, while we make every effort to safeguard your data once 
received on our servers via REDCap, given the nature of online surveys, as with anything involving the 
Internet, we can never guarantee the confidentiality of the data while still en route to us.” 
CAN YOUR TAKING PART IN THE STUDY END EARLY? 
If you decide to take part in the study you still have the right to decide at any time that you no 
longer want to continue. You will not be treated differently if you decide to stop taking part in the study. 
ARE YOU PARTICIPATING OR CAN YOU PARTICIPATE IN ANOTHER RESEARCH STUDY 
AT THE SAME TIME AS PARTICIPATING IN THIS ONE? 
You may take part in this study if you are currently involved in another research study.  It is 
important to let the investigator/your doctor know if you are in another research study.  You should also 
discuss with the investigator before you agree to participate in another research study while you are 
enrolled in this study. 
WHAT HAPPENS IF YOU GET HURT OR SICK DURING THE STUDY? 
If you believe you are hurt or if you get sick because of something that is due to the study, you 
should call Dr. Tovar at (409) 599-5984 immediately.  
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It is important for you to understand that the University of Kentucky does not have funds set aside 
to pay for the cost of any care or treatment that might be necessary because you get hurt or sick while 
taking part in this study. Also, the University of Kentucky will not pay for any wages you may lose if you 
are harmed by this study.   
The medical costs related to your care and treatment because of research related harm or 
frustration and embarrassment will be your responsibility.  
 
You do not give up your legal rights by signing this form. 
WILL YOU RECEIVE ANY REWARDS FOR TAKING PART IN THIS STUDY? 
You will not receive any rewards or payment for taking part in the study.   
WHAT IF YOU HAVE QUESTIONS, SUGGESTIONS, CONCERNS, OR COMPLAINTS? 
Before you decide whether to accept this invitation to take part in the study, please ask any 
questions that might come to mind now.  Later, if you have questions, suggestions, concerns, or 
complaints about the study, you can contact the investigator, Katelyn Hellman at (616) 881-9974.  If you 
have any questions about your rights as a volunteer in this research, contact the staff in the Office of 
Research Integrity between the business hours of 8am and 5pm EST, Mon-Fri at the University of 
Kentucky at 859-257-9428 or toll free at 1-866-400-9428. We will give you a signed copy of this consent 
form to take with you. 
 
WHAT IF NEW INFORMATION IS LEARNED DURING THE STUDY THAT MIGHT AFFECT 
YOUR DECISION TO PARTICIPATE? 
 
If the researcher learns of new information in regards to this study, and it might change your 
willingness to stay in this study, the information will be provided to you.  You may be asked to sign a new 
informed consent form if the information is provided to you after you have joined the study.  
 
POTENTIAL FUTURE USE  
 
Contacting Research Subjects for Future Studies 
 
Do you give your permission to be contacted in the future by Katelyn Hellman or Dr. Tovar (regarding 
your willingness to participate in future research studies about how to prevent, detect, or treat acute 
sinusitis and  the benefits of the education session? 
   Yes     No  _________Initials 
WHAT ELSE DO YOU NEED TO KNOW? 
There is a possibility that the data/tissue/specimens/blood collected from you may be shared with 
other investigators in the future.  If that is the case the data/tissue/specimen/blood will not contain 
information that can identify you unless you give your consent/authorization or the UK Institutional Review 
Board (IRB) approves the research.  The IRB is a committee that reviews ethical issues, according to 
federal, state and local regulations on research with human subjects, to make sure the study complies 
with these before approval of a research study is issued. 
 
 
_____________________________________________                 ____________ 
Signature of person agreeing to take part in the study            Date 
  
_____________________________________________ 
Printed name of person agreeing to take part in the study 
  
_____________________________________________     ____________ 
Name of [authorized] person obtaining informed consent            Date 
  
_________________________________________ 
Signature of Principal Investigator or Sub/Co-Investigator   
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Appendix C 
Form F 
Survey Cover Letter 
To : UK General Internal Medicine and Geriatrics Providers:  
The purpose of the study is to align antibiotic prescribing for adults with acute sinusitis with 
PQRS measures #331 and #332 through: a) Assess current antibiotic prescribing patterns and 
provider knowledge for acute sinusitis in adult patients, b), develop and implement an education 
and evidence based ASP based on PQRS measures #331 and #332, and c) Evaluate provider 
knowledge and practices before after ASP implementation to assess effect of ASP as evidenced 
by changes in antibiotic prescribing and provider knowledge.   
Although you will not get personal benefit from taking part in this research study, your 
responses may help us understand more about current antibiotic prescribing patterns for adults 
treated for acute sinusitis.  Minimal risks and discomforts are expected to be associated with 
participation in this study.     
 
We hope to receive completed questionnaires from about _30_ people, so your answers 
are important to us.  Of course, you have a choice about whether or not to complete the 
survey/questionnaire, but if you do participate, you are free to skip any questions or 
discontinue at any time.   
 
The survey/questionnaire will take about _5-10_ minutes to complete.   
 
There are no known risks to participating in this study. 
 
 
Your response to the survey is anonymous which means no names will appear or be 
used on research documents, or be used in presentations or publications.  The research team 
will not know that any information you provided came from you, nor even whether you 
participated in the study. 
 
Please be aware, while we make every effort to safeguard your data once received on 
our servers via REDCap, given the nature of online surveys, as with anything involving the 
Internet, we can never guarantee the confidentiality of the data while still en route to us. 
 
If you have questions about the study, please feel free to ask; my contact information is 
given below.  If you have complaints, suggestions, or questions about your rights as a research 
volunteer, contact the staff in the University of Kentucky Office of Research Integrity at 859-257-
9428 or toll-free at 1-866-400-9428. 
 
Thank you in advance for your assistance with this important project.  This survey will be 
open between February 6th – February 10th.    
 
Sincerely, 
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Katelyn Hellman  
College of Nursing, University of Kentucky 
PHONE:  616-881-9974 
E-MAIL:  kmde222@uky.edu 
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Appendix D 
 
Form E 
Include in IRB Application to 
Waive Requirement for Informed Consent  
If you are requesting IRB approval for waiver of the requirement for the informed consent 
process, or alteration of some or all of the elements of informed consent (i.e. medical record review, 
deception research, or collection of biological specimens), complete Section 1 and Section 2 of this form 
and include it with your IRB application submission.  
Note:  The IRB does not approve waiver or alteration of the consent process for research that is 
subject to FDA regulations, except for planned emergency/acute care research as provided under FDA 
regulations.  Contact ORI for regulations that apply to single emergency use waiver or acute care research 
waiver (859-257-9428). 
SECTION 1 
Check the appropriate item: 
 
 1) I am requesting waiver of the requirement for the informed consent process. 
  
 2) I am requesting alteration of the informed consent process. 
 If you checked the box for this item, describe which elements of consent will be altered, and/or 
omitted, and justify the alteration. 
  
  
 
SECTION 2 
 
The IRB may consider your request provided that all of the following conditions apply to your 
research and are appropriately justified.  Explain in the space provided for each condition how it applies 
to your research. 
 
a
) The research involves no more than minimal risk to the subject. 

The baseline chart review will be retrospective collect information on patients which has already 
occurred.  The post-assessment chart review will collect data after a voluntary education intervention which 
is not intended to replace clinical judgement.  The data will be collected retrospectively.   
  
b
) The rights and welfare of subjects will not be adversely affected. 

No identifying patient information will be maintained.  Clinical judgement of providers will not be 
compromised.   
  
c
) The research could not practicably be carried out with out the waiver or alteration. 
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
Data collected will be retrospective on 206 patients, informed consent cannot be obtained from 
individual patients without breaching confidentiality of treatment.   
  
d
)
Whenever possible, the subject will be provided with additional pertinent information after they 
have participated in the study. 
 Results of the study will be provided to UK General Internal Medicine and Geriatrics. 
  
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Appendix E 
Assessing Antibiotic Prescribing Behavior for Adults with Acute Sinusitis 
  Chart Audit Tool 
 
Study number:_______________ 
Gender:_____________________ 
Age:________________________ 
Race:_______________________ 
Insurance:___________________ 
 
At adult acute bacterial sinusitis visits ICD9: 461.0, 461.1, 461.2, 461.3, 461.8, 461.9; 
ICD10: J01.00, J01.10, J01.20, J01.30, J01.40, J01.80, J01.90, patient encounter codes 
acceptable are: 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99281, 99282, 
99283, 99284, 99285, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99324, 99325, 99326, 
99327, 99328, 99334, 99335, 99336, 99337, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 
99349, 99350 
 
PQRS Measures 
Information Yes No Comments 
Was the patient symptomatic for 
greater than 10 days, less than 4 
weeks  
 
 
 
  
Was the patient exhibiting signs 
and symptoms worsening within 10 
days after initial improvement, 
“double sickening” 
 
   
Were the symptoms: purulent 
nasal drainage, nasal obstruction, 
facial pain-pressure-fullness or 
both 
   
Was the patient prescribed an 
antibiotic? 
   
Was the first-line antibiotic 
amoxicillin with or without 
clavulanate?  
   
Was an allergy to penicillin 
documented? 
   
Was an indication to use 
alternative first line treatment 
documented? 
   
Was the dose of antibiotic 5-10 
days? 
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Appendix F 
Confidential 
 
M1 
Pre-Assessment Provider Knowledge 
Survey 
 
Please complete the survey below. 
 
 
 
 
1) Are you aware of PQRS measure #331? Yes 
No 
2) Are you aware of PQRS measure #332? 
 
Yes 
No 
3) 
 
How many days after sinusitis symptom onset are 
antibiotics appropriate 
3 days of diagnosis or 5 days of symptom onset 
7 days of diagnosis or 10 days of symptom onset 
7-10 days 
3-5 days 
4) What is the first line antibiotics of choice? Amoxicillin only 
Amoxicillin-Clavulanate only 
Macrolide 
Amoxicillin with or without Clavulanate 
5) What are at least three indications to not use the  
 first line antibiotic of choice? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6) What are key symptoms of acute sinusitis? 
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Appendix G 
Confidential 
 
M2 
Post-Assessment Provider Knowledge 
Survey 
 
Please complete the survey below. 
 
 
 
 
1) Are you aware of PQRS measure #331? Yes 
No 
2) Are you aware of PQRS measure #332? 
 
Yes 
No 
3) 
 
How many days after sinusitis symptom onset are 
antibiotics appropriate 
3 days of diagnosis or 5 days of symptom onset 
7 days of diagnosis or 10 days of symptom onset 
7-10 days 
3-5 days 
4) What is the first line antibiotics of choice? Amoxicillin only 
Amoxicillin-Clavulanate only 
Macrolide 
Amoxicillin with or without Clavulanate 
5) What are at least three indications to not use the  
 first line antibiotic of choice? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6) What are key symptoms of acute sinusitis?  
 
7) 
 
Did you complete the baseline provider knowledge 
survey? 
 
yes 
no 
 
 
 
 
